-
Posted: January 26th, 2010, 3:17pm EST
Biocon's clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation SIRO Clinpharm.
-
Posted: January 22nd, 2010, 10:42am EST
Biocon Limited today signed an MoU with Malaysia's Biotechnology Corporation (BiotechCorp) to explore collaboration and potential investment in Malaysia's biotechnology industry.
-
Posted: December 20th, 2009, 3:30pm EST
Reliance Life Sciences (RLS), a company promoted by Reliance Industries’ chairman, Mukesh Ambani, is looking at biopharmaceuticals as a huge thrust area.
-
Posted: December 20th, 2009, 3:30pm EST
Reliance Life Sciences (RLS), a company promoted by Reliance Industries’ chairman, Mukesh Ambani, is looking at biopharmaceuticals as a huge thrust area.
-
Posted: December 7th, 2009, 1:38pm EST
World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matrix Laboratories, has exited the biotech company by selling its stake to promoters.
-
Posted: December 7th, 2009, 1:38pm EST
World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matrix Laboratories, has exited the biotech company by selling its stake to promoters.
-
Posted: December 7th, 2009, 1:38pm EST
World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matrix Laboratories, has exited the biotech company by selling its stake to promoters.
-
Posted: November 10th, 2009, 11:56pm EST
US firm plans Rs 500 crore unit next to Tata Motors’ project.
-
Posted: November 10th, 2009, 11:56pm EST
US firm plans Rs 500 crore unit next to Tata Motors’ project.
-
Posted: November 10th, 2009, 11:56pm EST
US firm plans Rs 500 crore unit next to Tata Motors’ project.